113 related articles for article (PubMed ID: 36167746)
21. VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer.
Kim JY; Kim EK; Lee WM; Hong YO; Lee H
APMIS; 2020 Oct; 128(10):543-551. PubMed ID: 32794608
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of DLL4 expression in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Okumura H; Kurahara H; Uchikado Y; Setoyama T; Kita Y; Kijima Y; Nishizono Y; Nakajo A; Owaki T; Ueno S; Natsugoe S
J Exp Clin Cancer Res; 2013 Jul; 32(1):46. PubMed ID: 23898884
[TBL] [Abstract][Full Text] [Related]
23. High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL
Angiogenesis; 2013 Apr; 16(2):343-51. PubMed ID: 23108591
[TBL] [Abstract][Full Text] [Related]
24. Loss of HES-1 Expression Predicts a Poor Prognosis for Small Intestinal Adenocarcinoma Patients.
Kim JW; Jun SY; Ylaya K; Chang HK; Oh YH; Hong SM; Chung JY; Hewitt SM
Front Oncol; 2020; 10():1427. PubMed ID: 32974155
[No Abstract] [Full Text] [Related]
25. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
Qiu XX; Chen L; Wang CH; Lin ZX; Chen BJ; You N; Chen Y; Wang XF
World Neurosurg; 2016 Apr; 88():447-458. PubMed ID: 26546995
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.
Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P
Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179
[TBL] [Abstract][Full Text] [Related]
27. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
[TBL] [Abstract][Full Text] [Related]
29. Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells.
Caolo V; van den Akker NM; Verbruggen S; Donners MM; Swennen G; Schulten H; Waltenberger J; Post MJ; Molin DG
J Biol Chem; 2010 Dec; 285(52):40681-9. PubMed ID: 20959466
[TBL] [Abstract][Full Text] [Related]
30. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
[TBL] [Abstract][Full Text] [Related]
31. Role of Notch signaling pathway in gastric cancer: a meta-analysis of the literature.
Du X; Cheng Z; Wang YH; Guo ZH; Zhang SQ; Hu JK; Zhou ZG
World J Gastroenterol; 2014 Jul; 20(27):9191-9. PubMed ID: 25083094
[TBL] [Abstract][Full Text] [Related]
32. Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma.
Wang W; Yu Y; Wang Y; Li X; Bao J; Wu G; Chang H; Shi T; Yue Z
Oncol Lett; 2014 Dec; 8(6):2627-2633. PubMed ID: 25364440
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.
Donnem T; Andersen S; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Cancer; 2010 Dec; 116(24):5676-85. PubMed ID: 20737536
[TBL] [Abstract][Full Text] [Related]
34. Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients.
Candy PA; Phillips MR; Redfern AD; Colley SM; Davidson JA; Stuart LM; Wood BA; Zeps N; Leedman PJ
Br J Cancer; 2013 Aug; 109(4):1023-30. PubMed ID: 23900217
[TBL] [Abstract][Full Text] [Related]
35. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.
Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J
World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223
[TBL] [Abstract][Full Text] [Related]
36. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer.
Jubb AM; Soilleux EJ; Turley H; Steers G; Parker A; Low I; Blades J; Li JL; Allen P; Leek R; Noguera-Troise I; Gatter KC; Thurston G; Harris AL
Am J Pathol; 2010 Apr; 176(4):2019-28. PubMed ID: 20167860
[TBL] [Abstract][Full Text] [Related]
37. Delta-Like 4-Notch signaling regulates trophoblast migration and invasion by targeting EphrinB2.
Luo Q; Zhang W; Liu X; Zheng Y; Gao H; Zhao Y; Zou L
Biochem Biophys Res Commun; 2020 Jul; 527(4):915-921. PubMed ID: 32430173
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of tumour deposit and perineural invasion status in colorectal cancer patients: a SEER-based population study.
Mayo E; Llanos AA; Yi X; Duan SZ; Zhang L
Histopathology; 2016 Aug; 69(2):230-8. PubMed ID: 26802566
[TBL] [Abstract][Full Text] [Related]
39. Neuritin promotes angiogenesis through inhibition of DLL4/Notch signaling pathway.
Yang L; Wang X; Sun J; Liu C; Li G; Zhu J; Huang J
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):663-672. PubMed ID: 33787845
[TBL] [Abstract][Full Text] [Related]
40. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH
BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
